Working Capital Efficiency
The data from Quater 2 in 2020 to Quater 1 in 2021 includes 3 quarters.

Liabilities on Revenue
Current assets on Revenue

Cost Efficiency
The data from Quater 2 in 2020 to Quater 1 in 2021 includes 3 quarters.

Ratio of Retained Earnings to Revenue
Year 2020 Quarter 2: Ratio of Retained Earnings to Revenue -25735200000.0 (%).Trend:Decrease 184.53% than previous quarter
Year 2020 Quarter 3: Ratio of Retained Earnings to Revenue -24217500000.0 (%).Trend:Decrease 5.9% than previous quarter
Year 2021 Quarter 1: Ratio of Retained Earnings to Revenue -22651600000.0 (%).Trend:Decrease 6.47% than previous quarter

Overall: increasing (-11.98%). Fluctuation: **Significant** (high variation).

Selling, General & Administrative (SG&A) Expense Ratio

Invest Efficiency
The data from Quater 2 in 2020 to Quater 1 in 2021 includes 3 quarters.

Retained Earning on Assets
Year 2020 Quarter 2: Retained Earning on Assets -1.97 (%).Trend:Decrease 184.91% than previous quarter
Year 2020 Quarter 3: Retained Earning on Assets -1.92 (%).Trend:Decrease 2.54% than previous quarter
Year 2021 Quarter 1: Retained Earning on Assets -1.78 (%).Trend:Decrease 7.29% than previous quarter

Overall: increasing (-9.64%). Fluctuation: **Significant** (high variation).

Earning Per Share
Year 2020 Quarter 2: Earning Per Share -11.33 (USD).Trend:Increase 2732.5% than previous quarter
Year 2020 Quarter 3: Earning Per Share -10.9 (USD).Trend:Decrease 3.8% than previous quarter
Year 2021 Quarter 1: Earning Per Share 0.26 (USD).Trend:Decrease 102.39% than previous quarter

Overall: increasing (-102.29%). Fluctuation: **Significant** (high variation).



Financial performance from Q2 2020 to Q1 2021 reveals a complex picture of declining trends, followed by a slight increase in earnings per share. The ratio of retained earnings to revenue decreased by 11.98% overall, with notable fluctuations quarter-to-quarter. Retained earnings on assets showed a similar decline by 9.64% overall, and with substantial swings. Earnings per share overall decreased by 102.29% but with considerable quarter-to-quarter inconsistencies.